Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry
In a contemporary national registry of hospitalized patients with AMI who underwent PCI, Black and Hispanic patients were less likely to be discharged on a high-potency P2Y12 inhibitor irrespective of socioeconomic status. These findings highlight an opportunity to achieve equity in guideline-directed AMI pharmacotherapies to improve outcomes.
Authors
- Ian C. Gilchrist (ORCID: https://orcid.org/0000-0001-8525-8454)
- Lisa A. Kaltenbach
- Jennifer A. Rymer (ORCID: https://orcid.org/0000-0001-9841-2393)
- Islam Y. Elgendy (ORCID: https://orcid.org/0000-0001-9853-7591)
- D. Wojdyla
- Binita Shah (ORCID: https://orcid.org/0000-0001-8872-8001)
- Rebecca Young
- Hend Mansoor
Institutions
- Dartmouth College (US)
- Dartmouth–Hitchcock Medical Center (US)
- University of Kentucky (US)
- Duke University (US)
- Clinical Research Institute (US)
- New York University (US)
Publication Details
- Journal
- Circulation Cardiovascular Interventions
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1161/circinterventions.125.015600
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00